Cato Daily Podcast cover image

Would Wider Access to GLP-1s Throttle Addiction?

Cato Daily Podcast

00:00

Exploring the Off-Label Use of GLP-1 Drugs in Addiction Treatment

This chapter explores the careful approach required in using GLP-1 drugs for addiction treatment, focusing on ongoing research related to their effectiveness and safety. It also discusses off-label prescribing and its impacts on patients, emphasizing the need for further clinical trials as these medications gain traction for uses outside traditional diabetes and obesity treatment.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app